| Literature DB >> 33952657 |
Robert I Colautti1, Prameet M Sheth2,3,4,5, Calvin P Sjaarda6,7, Jennifer L Guthrie8, Samira Mubareka9,10, Jared T Simpson11,12, Bettina Hamelin13, Henry Wong2, Leanne Mortimer14,15,16, Robert Slinger16,17, Andrew G McArthur18,19,20, Marc Desjardins14,21, Allison McGeer22,23, Tony Mazzulli8,10,22, Katya Douchant3, Danielle Brabant-Kirwan24, Ramzi Fattouh25, Aaron Campigotto10,26, Samir N Patel8,10, Nahuel Fittipaldi8,10,23.
Abstract
Genome-wide variation in SARS-CoV-2 reveals evolution and transmission dynamics which are critical considerations for disease control and prevention decisions. Here, we review estimates of the genome-wide viral mutation rates, summarize current COVID-19 case load in the province of Ontario, Canada (5 January 2021), and analyze published SARS-CoV-2 genomes from Ontario (collected prior to 24 November 2020) to test for more infectious genetic variants or lineages. The reported mutation rate (∼10-6 nucleotide [nt]-1 cycle-1) for SARS-CoV-2 is typical for coronaviruses. Analysis of published SARS-CoV-2 genomes revealed that the G614 spike protein mutation has dominated infections in Ontario and that SARS-CoV-2 lineages present in Ontario have not differed significantly in their rate of spread. These results suggest that the SARS-CoV-2 population circulating in Ontario has not changed significantly to date. However, ongoing genome monitoring is essential for identification of new variants and lineages that may contribute to increased viral transmission.Entities:
Keywords: COVID-19; G614D; PANGOLIN lineage; SARS-CoV-2; epidemiology; genetics; infectious disease; public health
Mesh:
Substances:
Year: 2021 PMID: 33952657 DOI: 10.1128/mSphere.00011-21
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389